The gridlock in Washington, D.C. has bogged down possible legislative solutions, leaving states to take the lead on curbing insulin prices.

The must-pass bill will include provisions related to generic drug competition and biologic drug competition.

Omnicare, which has been in hot water before, provides pharmacy services to long-term care facilities.

Diabetes continues to be a complex issue for both employers and employees.